BofA Securities Double Downgrades Achilles Therapeutics (ACHL) to Underperform
Tweet Send to a Friend
(Updated - December 14, 2023 6:51 AM EST)
BofA Securities analyst Tazeen Ahmad downgraded Achilles Therapeutics (NASDAQ: ACHL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad downgraded Achilles Therapeutics (NASDAQ: ACHL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
